GSDMD in regulated cell death: A novel therapeutic target for sepsis

Xiangli Ma,Yujie Lin,Ling Zhang,Shaoyi Miao,Haidan Zhang,Hongyao Li,Xu Fu,Li Han,Peiwu Li
DOI: https://doi.org/10.1016/j.intimp.2024.112321
IF: 5.714
2024-05-25
International Immunopharmacology
Abstract:Sepsis is a life-threatening multi-organ dysfunction syndrome caused by an abnormal host response to infection. Regulated cell death is essential for maintaining tissue homeostasis and eliminating damaged, infected, or aging cells in multicellular organisms. Gasdermin D, as a member of the gasdermin family, plays a crucial role in the formation of cytoplasmic membrane pores. Research has found that GSDMD plays important roles in various forms of regulated cell death such as pyroptosis, NETosis, and necroptosis. Therefore, through mediating regulated cell death, GSDMD regulates different stages of disease pathophysiology. This article mainly summarizes the concept of GSDMD, its role in regulated cell death, its involvement in organ damage associated with sepsis-related injuries mediated by regulated cell death via GSDMD activation and introduces potential drugs targeting GSDMD that may provide more effective treatment options for sepsis patients through drug modification.
pharmacology & pharmacy,immunology
What problem does this paper attempt to address?